Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA2 gene mutations in Greek patients with familial breast cancer.

Human mutation - 1 Jan 2002

Armakolas Athanasios, Ladopoulou Angela, Konstantopoulou Irene, Pararas B, Gomatos Ilias P, Kataki Agapi, Konstadoulakis Manoussos M, Stathopoulos George P, Markopoulos Christopher, Leandros Emmanouil, Gogas Ioannis, Yannoukakos Drakoulis, Androulakis George

Abstract excerpt

Family history is a well-recognized risk factor for the development of breast cancer. The isolation of BRCA1 and BRCA2 genes, the two major predisposing genes in familial and to early onset breast and ovarian cancer, has resulted to the identification of a large number of families with mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genes, BRCA2

Share to Genotype

Share to Greece

Share to Phenotype

Source

Identifiers

PMID: 11754111
DOI: 10.1002/humu.9003

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11754111-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA2 gene mutations in Greek patients with familial breast cancer.PMID 11754111Read ↗

High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.Semantic proximity Read ↗

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.Semantic proximity Read ↗

Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.Semantic proximity Read ↗

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.Semantic proximity Read ↗

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.Semantic proximity Read ↗

BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.Semantic proximity Read ↗

Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients.Semantic proximity Read ↗

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.Semantic proximity Read ↗

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.Semantic proximity Read ↗

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.Semantic proximity Read ↗

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patientsSemantic proximity Read ↗

BRCA1 mutation analysis in breast/ovarian cancer families from Greece.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.